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Purpose: Bladder pain is a debilitating symptom of many urological conditions.
There is no generally effective treatment. Abnormal urothelial turnover is common
to multiple disease states but the specific components of urothelial injury and the
resultingmolecular signals that lead to bladder pain are unknown.We examinedmouse
models of bladder injury induced by uropathogenic Escherichia coli, protamine sulfate
(Sigma®) and bacterial lipopolysaccharide to identify cellular and molecular
correlates underlying pain sensitization in response to the stimuli.
Materials and Methods: C57BL/6 female mice (Jackson Laboratory, Bar Harbor,
Maine) were given intravesicular protamine sulfate, lipopolysaccharide or uro-
pathogenic E. coli. The impact of each on nociception was determined bymeasuring
the evoked visceromotor response to bladder distention 24 hours after inoculation.
Levels of pyuria and tissue inflammation were examined by urinary cytology and
tissue histology. Quantitative polymerase chain reaction and gene expression anal-
ysis were used to identify injury profiles associated with nociception.
Results: Protamine sulfate treatment was significantly analgesic upon bladder
distention. Protamine treated bladders did not show pyuria or extensive tissue
damage. Protamine injury was associated with a global decrease in the expression of
inflammation associated genes. In contrast, uropathogenic E. coli injury significantly
increased the nociceptive response to bladder distention. Lipopolysaccharide treat-
ment did not affect nociception. Finally, injury induced expression of inflamma-
tion associated genes correlated with nociceptive responses.
Conclusions: Protamine treatment of the bladder is analgesic and tissue protective,
and it suppresses the inflammatory cytokine expression normally associated with
nociception. Also, the injury modalities that result in differential tissue response
patterns provide an innovative method for identifying mediators of visceral pain.
Abbreviations
and Acronyms
GO Gene Ontology
hpi hours after inoculation
IBC intracellular bacterial
community
IC/BPS interstitial cystitis/
bladder pain syndrome
IL interleukin
LPS lipopolysaccharide
PCR polymerase chain reaction
PMN polymorphonuclear
neutrophils
PS protamine sulfate
qPCR quantitative PCR
UPEC uropathogenic
Escherichia coli
UTI urinary tract infection
VMR visceromotor response
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ical conditions and abnormal urothelial
turnover is common to multiple pain-
ful disease states, including IC/BPS
and UTIs. IC/BPS and UTIs share the
common clinical feature of increasing
pelvic pain upon bladder filling (dis-
tention), leading to urinary frequency
and urgency, with bladder pain the
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visits.1 IC/BPS affects 3% to 6% of
women in the United States.2 UTIs,
which are caused primarily by UPEC,
affect 13 million women each year.3
Urothelial cell sloughing and defec-
tive urothelial barriers characterize
patients with recurrent/chronic UTIs
and IC/BPS. Disruption of the nor-
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injury and pain sensitization.4 Although the urothe-
lium is recognized as a nociceptive (pain) sensing
structure that modulates and transmits noxious
stimuli through mediators such as cytokines and
adenosine triphosphate,5,6 it is unclear how damage
to each tissue layer of the bladder affects pain, while
the specific molecular components generated by
urothelial tissue injury that lead to bladder pain are
unknown.
The urothelium shows remarkable ability to renew
in response to environmental insults, eg pathogens
and cyto-injurious factors. Intriguingly, the regenera-
tive responses to injury modalities are distinct.7 A
murine model of bladder injury resulting from UPEC
infection leads to urothelial barrier damage and in-
flammation within 24 hours.7 Urothelial regenera-
tion following infection is fueled by rapid activation
of stem and early progenitor cells.7 In contrast, in-
travesicular treatment with PS, a highly cationic
peptide that causes increased ionic permeability of
the urothelium and chemically exfoliates urothelial
barrier cells within 12 hours of instillation, does not
induce inflammation.7,8 Rather than activating
urothelial stem cells, PS induced injury appears to
activate epithelial repair via transiently amplifying
cells.7
We used these 2 well characterized models of
urothelial damage to examine the cellular and mo-
lecular mechanisms underlying pain sensitization in
response to injury and inflammation. We report
striking protection from distention induced bladder
pain upon PS injury, which is in contrast to the
nociceptive response triggered by UPEC infection.
Urine cytology and tissue histology showed that PS
treatment protects against pyuria and distention
induced tissue damage. Finally, we identified a mo-
lecular profile of globally down-regulated inflamma-
tory cytokines with an increase in transient ampli-
fying cell signatures, thus, providing novel insights
into the mechanisms of nociception and PS induced
analgesia.
MATERIALS AND METHODS
Mice
All animal experimental protocols were approved by the
Washington University institutional animal care and use
committee. Nine to 13-week-old female C57BL/6 mice
were used for all experiments. Animals were housed on a
12-hour light/dark cycle and allowed free access to food
and water.
Intravesicular Inoculations
UTI89, a pathogenic Escherichia coli strain, was grown
statically in Luria-Bertani broth for 17 hours at 37C. PS
(50 l, 10 mg/ml in water) or 107 cfu/ml bacterial suspen-
sions in saline were intravesicularly administered.7,9 Lit-ter mate controls received 50 l sterile 1 saline (Thermo
Fisher, Waltham, Massachusetts). Inflammatory damage
was induced with LPS from E. coli strain 055:B5 (Sigma)
(50 l, 100 g/ml) by intravesicular inoculation once daily
for 4 days.10 Litter mate controls received 4-day adminis-
tration of 50 l 1 sterile saline. After intravesicular
administration the catheter was removed. All animals
were maintained under isoflurane anesthesia for 10 min-
utes before spontaneous waking.
VMR Analysis
At 24 hpi the mice were lightly anesthetized using isoflu-
rane and the VMR was recorded in each. Visceral nocicep-
tion was quantified by electromyographic recording of the
abdominal muscle response to bladder distention, as de-
scribed previously.11–13 For each distention VMR signals
were subtracted from baseline, rectified and integrated
during 20 seconds to quantify the AUC.
Tissue Preparation and Inflammation Scoring
Immediately after the completion of VMR analysis, the
mice were sacrificed. Bladder and kidney tissues were
aseptically removed. Tissues were fixed in methacarn
(60% methanol, 30% chloroform and 10% glacial acetic
acid), embedded in paraffin, sectioned and stained with
hematoxylin and eosin. Photomicrographs were taken us-
ing a NanoZoomer HT (Hamamatsu, Bridgewater, New
Jersey). They were observed in blinded fashion to score
the level of tissue damage and inflammation using a mod-
ified semiquantitative scoring system, including 0—nor-
mal, 1A—subepithelial edema without cellular infiltrate,
1B—subepithelial inflammatory infiltration (focal and
multifocal), 2—edema and subepithelial inflammatory in-
filtration (diffuse), 3—marked subepithelial inflammatory
cells with necrosis and PMNs in and on bladder mucosal
epithelium, 4—grade 3 criteria plus inflammatory infil-
trate extending into muscle and 5—loss of surface epithe-
lium (necrosis with full-thickness inflammatory infiltra-
tion.14
Urine Collection, and Urine
Sediment and Bacterial Titer Analysis
Urine samples were collected before intravesicular treat-
ment, at 6 and 24 hpi, and twice during VMR analysis.
Urine specimens collected before VMR were obtained as
previously published.14 During VMR rest periods, cathe-
terized animals had gentle pressure applied to the skin
just below the occiput. Voided urine was gathered by pi-
pette and transferred to sterile tubes. Nonnoxious pres-
sure (30 mm Hg or less distention) and noxious pressure
(40 mm Hg or greater) urine samples were collected from
each mouse and pooled.
Urine sediments were obtained as previously de-
tailed,14 fixed for 15 minutes in acetic acid/alcohol and
Papanicolaou stained according to manufacturer instruc-
tions (PROTOCOL, Thermo Fisher). Photomicrographs
were taken using a Nikon® Eclipse E800 microscope and
analyzed using National Institutes of Health Image J.
Stained urine sediments were examined and scored in a
blinded manner by light microscopy on a 0 to 4 scale,
where 0 indicated less than 1 and 4 indicated greater than
20 PMNs per high power field, as previously described.14Pretreatment urine showed no evidence of superficial cell
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Bladder infection was confirmed by spotting serial dilu-
tions of urine on Luria-Bertani agar plates and quantify-
ing the cfu value after overnight growth at 37C.
DNA Microarray Inflammatory Gene Profiling
Total cellular RNA was isolated using an RNeasy® Kit
from whole mouse bladders at 3 and 6 hpi for UPEC, and
at 3, 6, 24 and 48 hpi for PS in 8 to 12-week-old female
mice with 10 mice per injury per time point in 2 indepen-
dent experiments. cRNA was generated from pooled RNA
and used to interrogate U74 (UPEC) and 430 2.0 whole
mouse genome GeneChip® microarrays, as previously
published.7 Genes and GO terms that were enriched for
each treatment were determined using dChip and GOurmet
software.15 To identify GO terms that were increased fol-
lowing PS treatment, enriched genes were associated with
GO terms. GO terms that increased by 25% or greater and
represented 3% or greater of the genes expressed at 1 or
more time points were determined. All such GO terms
were plotted.
Real-Time qPCR
Total cellular bladder RNA, which was TRIzol® isolated
according to manufacturer protocols, was pooled from 5 to
7 female mice at ages 6 to 11 weeks at 3.5, 6 and 24 hpi.
cDNAs were reverse transcribed and assayed in triplicate.
Gene expression changes were determined using the 
threshold count method (normalized to 18s rRNA and then
to saline treated mice), as previously described.7,16 Primer
sequences were obtained from the qPCR PrimerBank public
database (http://pga.mgh.harvard.edu/primerbank/index.html)
(see table).17
Statistical Analysis
Mean  SEM VMR measurements were analyzed by
2-way ANOVA with Bonferroni post hoc analysis. Inflam-
mation scores were analyzed using the 2-tailed Mann-
Whitney U-tests as appropriate, to compare injuries to
respective controls.
Inflammatory genes differentially regulated by PS or UPEC me
Gene
Primer (5’-3’)
Forward Reve
IL-1 5’-GCAACTGTTCCTGAACTCAACT 5’-ATCTTTTGGGGT
IL-6 5’-CCAGAAACCGCTATGAAGTTCCT 5’-CACCAGCATCA
Socs3 5’-CTTCCCATGCCGCTCACA 5’-CCCAGCCCCAT
IL-4 5’-GGTCTCAACCCCCAGCTAGT 5’-GCCGATGATCT
KC 5’-ACCCAAACCGAAGTCATAGCC 5’-TTCAGGGTCAA
Cinc-1 5’-CTGGGATTCACCTCAAGAACATC 5’-CAGGGTCAAGG
Ccxl-10 5’-CCAAGTGCTGCCGTCATTTTC 5’-GGCTCGCAGGG
Tnf- 5’-CCCTCACACTCAGATCATCTTCT 5’-GCTACGACGTG
Stat5b 5’-CACCCGCAATGATTACAGCG 5’-CTCTTGATTCGT
IL-10 5’-GCTCTTACTGACTGGCATGAG 5’-CGCAGCTCTAG
IL-7 5’-TTCCTCCACTGATCCTTGTTCT 5’-AGCAGCTTCCTT
SOCS7 5’-TCAGTCGCCTGTTTCGCAC 5’-GTTTCCTCCCCG
Tgf-1 5’-CTCCCGTGGCTTCTAGTGC 5’-GCCTTAGTTTGG
IL-1 5’-GCACCTTACACCTACCAGAGT 5’-AAACTTCTGCCT
IL-1Ra 5’-GCTCATTGCTGGGTACTTACAA 5’-CCAGACTTGGC
18S 5’-CGGCTACCACATCCAAGGAA 5’-GCTGGAATTACCGCGGCRESULTS
PS is Analgesic on Distention VMR Assay
We hypothesized that various injuries to the bladder
architecture and the respective renewal responses
may have differential effects on the pain-like re-
sponse to bladder distention. We previously used the
VMR to reliably measure hypersensitivity in a chem-
ically induced bladder inflammation model.11–13 This
demonstrated that the VMR is potentiated by in-
flammation (mustard oil, cyclophosphamide and zy-
mosan) and inhibited by analgesics (morphine and
intravesicular lidocaine). Abdominal VMR is mea-
sured as the electromyographic signals of the exter-
nal oblique muscle. Behaviorally it corresponds to
abdominal withdrawal and nocifensive guarding when
an animal experiences pain while the bladder is dis-
tended. Therefore, the VMR is a surrogate measure of
distention evoked visceral nociception. It represents a
useful model for examining how different bladder inju-
ries affect distention induced bladder pain.
At 24 hours before VMR testing the mice received
UPEC, PS or saline (control) intravesicularly. As
expected, UPEC infection significantly increased the
evoked response to bladder distention compared to
controls (fig. 1, A). In contrast, PS treatment re-
sulted in a significantly decreased VMR compared to
controls (fig. 1, A). To determine whether the differ-
ential effect was due to an absent inflammatory
response to PS injury, we treated a separate cohort
of mice with intravesicular LPS every 24 hours for 4
days. This regimen was previously shown to elicit an
inflammatory response.10 Multidose LPS injury did
not significantly alter the VMR compared to that in
mice similarly treated with saline (fig. 1, B).
injury
Amplicon
Length (bp)
Injury Change vs Noninjured Bladder
(fold/hpi)
UPEC PS
ACT 89 126.5/6 –14.5/24
AGA 72 33.2/6 –7.7/24
CTT 110 7.1/6 –5.1/24
GTGAT 102 –4.1/24 3.6/24
CC 60 44.7/6 Not significant
TC 117 26.4/6 Not significant
TCAA 157 24.5/6 Not significant
AG 61 7.9/6 Not significant
GACA 117 –5.6/6 Not significant
GTG 105 –5.3/24 Not significant
ATCAC 200 –4.4/6 Not significant
GC 153 –3.6/6 Not significant
ATCTG 133 Not significant 5.4/24
GCTT 126 30.7/6 2.6/6
CAGG 132 5.7/6 9.4/24diated
rse
CCGTCA
GTCCCA
ACCTGA
CTCTCAA
GGCAAG
CAAGCC
ATGATT
GGCTAC
TTCAGG
GAGCAT
TGTATC
TATCCA
ACAGG
GACGA
ACAAGAT 187 — —
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To track urothelial injury and the impact of disten-
tion on injury profiles, urine was collected for sedi-
ment analysis. Saline treatment did not induce in-
jury, as measured by cytology (fig. 2, A, B, G and H).
UPEC injury results in IBC formation by 6 hpi.
Figure 1. PS injury was analgesic for bladder distention in female
mice. Data are shown as mean SEM arbitrary units. Saline, PS or
UPEC was administered intravesicularly before VMR (A). PS
treated mice showed significantly blunted VMR curve compared to
saline controls at 70 and 80 mm Hg pressure, eliciting statistically
significantly decreased VMRs. UPEC infected animals had signifi-
cantly higher VMR curve compared to saline controls and sensiti-
zation was seen at highest distention pressures of 70 and 80 mm Hg.
Triple plus signs indicate 2-way ANOVA with Bonferroni post
hoc test p 0.0001. Triple pound signs indicate 2-way ANOVA
with Bonferroni post hoc test p 0.0001. Double asterisks indi-
cate 2-way ANOVA with Bonferroni post hoc test p 0.001.
Triple asterisks indicate 2-way ANOVA with Bonferroni post
hoc test p 0.0001. LPS or saline administered 4 times during
4 days resulted in no significantly different VMR (B).These IBCs are shed into urine along with PMNs aspart of the host response.14 Accordingly, we identi-
fied IBCs and PMNs in urines from UPEC infected
mice (fig. 2, E and F). Analysis of urine samples from
PS treated mice showed minor cell sloughing before
distention (fig. 2, C and D). LPS injury resulted in
PMN recruitment by 6 hpi without associated loss of
superficial cells (fig. 2, I and J). Urine sediment
scored for inflammation at time points after injury
revealed that UPEC injury led to sustained pyuria
(urinary inflammation), whereas PS treatment did not
(fig. 2, K). LPS injury resulted in acute pyuria, which
resolved before a VMR (fig. 2, K).
PS Induces Hematuria at Noxious Pressure
Hemorrhagic cystitis is frequently induced upon
toxic chemical or infectious instillation in the blad-
der.18 We observed gross hematuria and microhema-
turia in the urine and sediment of 4 of 5 (80%) PS
injured animals (fig. 3, D). This was not evident in
urine before pathological bladder distention (fig. 3, C).
The incidence of hematuria from infectious injury was
far less prevalent (5 of 10mice or 50%) (fig. 3,E andF).
Four of 7 saline treated mice (57%) showed hallmarks
of distention induced microhematuria (fig. 3, A and B).
Moreover, hematuria and pyuria levels inversely cor-
related in PS and UPEC injuries (fig. 3, G).
PS Protects Against
Distention Induced Exacerbation of Injury
To track architectural changes as a result of distention
and injury bladders were collected immediately after
the completion of VMR recording. Controls showed
superficial cell loss and edema of the lamina propria
upon distention (fig. 4, A and B). Interestingly, PS
injury was not associated with extensive urothelial or
stromal damage and it demonstrated a relative lack of
tissue inflammation (fig. 4, C and E). In contrast, his-
tological characterization of UPEC injured bladders
after distention showed stromal edema, urothelial
damage and PMN influx, which were associated with
significantly higher tissue inflammation scores than in
saline treated controls (fig. 4, D and E).
PS Suppresses Proinflammatory Response
The bladder and urothelium produce distinct proin-
flammatory cytokines and chemokines in response
to inflammatory (eg CPX, LPS and substance P) and
infectious injury.10,14,19,20 Proinflammatory cyto-
kines, such as IL-6 and 1, can also lead to pain
hypersensitivity.21,22 To determine how PS treat-
ment regulates inflammation we compared gene ex-
pression in bladders from mice treated with PS to
those of mice infected with UPEC. UPEC infection
led to increased expression of genes with inflamma-
tion/immune response GO terms, whereas PS down-
regulated the expression of those genes (fig. 5, A and
B).15 Almost 10% of all genes enriched by UPEC at 6
hpi were characterized by the GO term inflamma-
ent m
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enriched by PS at 48 hpi were characterized as hav-
ing chemokine activity. This indicates that the mo-
lecular signatures of bladder responses to PS were
distinct from those induced by UPEC infection.
Microarray analysis after PS injury revealed in-
creased expression of genes that function in tissue
renewal mechanisms (fig. 5, C to E). At early time
points (6 hours and before) genes related to signal-
ing and cell adhesion were increased (fig. 5, C). By
12 hours GO terms such as DNA replication and cell
cycle, which characterize transient amplifying cells
but not stem cells, were induced (fig. 5, D).
We further confirmed these results by identifying
multiple gene expression profiles that correlated
with injury and its respective nociception response
on qPCR (see table and fig. 5, F to I). UPEC injury
triggered up-regulation of the early proinflamma-
tory cytokines IL-1 and 6, and of Socs3, a negative
regulator of IL-6. Furthermore, UPEC infection re-
sulted in down-regulation of the anti-inflammatory
cytokine IL-4 but PS treatment correlated with up-
regulation of this cytokine. In contrast, PS injury
Figure 2. Representative urine cytology images of PAP stained u
pyuria was not induced by PS treatment. Saline treated controls
represent highly keratinized vaginal cells. By 6 hpi UPEC (E) an
arrows) were found throughout UPEC urine (E and F). Black arr
saline, 6  4 LPS and 4  4 saline treated mice (K). Bars represresulted in down-regulation of IL-1, IL-6 and Socs3(fig. 5, F to I). We also identified molecular markers
that were up-regulated by UPEC as well as PS or
only regulated by UPEC or PS injury (see table).
DISCUSSION
We report that different bladder injuries result in
distinct alterations in nociception and provide sev-
eral lines of evidence that this is due to differential
effects on inflammation. Although UPEC infection
causes increased distention induced pain responses,
PS treatment decreases these responses. Our urine
and tissue inflammation assays, and gene expres-
sion analyses indicate that pain modulation corre-
lates with inflammation as a result of UPEC infec-
tion and inflammation suppression by PS treatment.
Chronic bladder pain is a debilitating condition
that is often unresponsive to conventional pain med-
ications. Injury induced sensitization can result in
acute pain that resolves but in some instances can
transition to chronic pain that persists even in the
absence of ongoing injury.21 Renewal after injury
typically requires barrier restoration and inflamma-
diments of control, and PS, UPEC or LPS injured mice show that
d minimal urothelial cell sloughing (A, B, G and H). Brown areas
(I) injuries showed pyuria but PS injury (C) did not. IBCs (white
dicate PMNs. Urinary inflammation scores of 6 PS, 10 UPEC, 8
edian scores. Scale bar indicates 50 m (A).rine se
showe
d LPS
ows intion resolution.7 The pathophysiology of conditions
mous
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lying mechanisms include occult UTI, noninfectious
idiopathic bladder inflammatory changes or urothe-
lial cell sloughing and regeneration. Patients can be
divided into subsets based on these underlying mech-
anisms. IC/BPS symptom exacerbation (flare-up)
bears a remarkable resemblance to recurrent UTIs
with increasing bladder pain and urinary urgency,
which in some cases may be associated with subclin-
ical UTI.23 Interstitial cystitis urine contains an an-
tiproliferative factor that inhibits the regeneration
of bladder epithelial cells in culture.6 For IC/BPS
and UTIs disruption of the normally impermeable
urothelial barrier by continued cell sloughing may
further impede renewal and lead to exacerbated tis-
sue injury and pain sensitization.4,6
The differential pain response to UPEC, LPS and
PS stimuli could in part be explained by the type of
Figure 3. Representative urine cytology images of PAP stained
distention induced hematuria in PS injured mice. Distention in
noxious distention pressure (greater than 40 mm Hg) hematuria
50 m (A). Individual PS and UPEC treated mice showed inver
hematuria (Urine RBC Score) (G). Dotted lines divide individualurothelial damage. Consistent with previous find-ings,11–13,24 UPEC infection resulted in visceral hy-
peralgesia and sensitization of nociceptive responses.
UPEC infection appears to activate the nociceptive
signals transmitted to the central nervous system. In-
hibition of a key receptor (mGluR5) in this pathway
results in a blunted VMR to UPEC infection.13 An
explanation for this activation could be the potent in-
flammatory response induced upon infection.
To better study the effect of inflammation on
VMR activation we simplified the complex host-
pathogen interaction in infection by focusing on in-
flammation induced by the surface antigen LPS.
Although adjuvant pretreatment has been used to
increase inflammation levels,10,20 we treated with
LPS alone to mimic the naïve bladder response to
bacterial products. In contrast to adjuvant adminis-
tration, although LPS treatment resulted in acute
pyuria, it was insufficient to induce changes in
sediments from control and injured mice reveal that noxious
sloughing of superficial cells from all animals (A, C and E). At
duced in control (B) and PS (D) treated mice. Scale bar indicates
relation between pyuria levels (Urine Inflammation Score) and
e scores.urine
duced
was in
se corVMR. Our findings suggest that acute inflammation
n-Whit
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study should focus on identifying how urothelial sta-
tus affects the integration of signals that are impor-
tant for nociception sensitization.
Although a foreign body in the bladder and other PS
injury models have resulted in cystitis-like inflamma-
tion,25,26 our PS injury model uses short catheteriza-
tion and incubation periods, and does not result in
inflammatory cystitis.7 PS injury was analgesic upon
distention and showed improved bladder histology
Figure 4. Histological analysis demonstrated that PS injury protect
injury or distention (A). H & E, scale bar indicates 250 m. Dotted b
distention (B) showed edema and superficial cell disruption (inset)
to distention (C). Urothelium and stromal compartment appeared
urothelial barrier disruption developed in UPEC infected bladders
layers (inset, arrowheads). Tissue inflammation scores of 12 saline
(E). Bars represent median scores. Asterisks indicate 2-tailed Mancompared to distended infectious injury and controls.To our knowledge this is the first report of urothelial
injury eliciting analgesia but the mechanism by which
PS treatment is protective is unknown.
Our microarray analysis revealed contrasting ex-
pression profiles in UPEC and PS treated bladders,
consistent with the differential effects of UPEC and
PS injury on the VMR. UPEC infection resulted in
increased proinflammatory gene expression changes
within 3 to 6 hours, consistent with the molecular
changes preceding urothelial stem cell activation.7,16
inst distention induced damage. Normal bladder histology without
icates inset. Scale bar indicates 25 m. Saline treated bladder after
eatment prevented exacerbated superficial cell loss or edema due
normal with no immune cell infiltration (inset). Edema and major
istention (D). Immune cells were evident in stromal and urothelial
 4 saline controls, and 6 PS, 9 UPEC and 5 4 LPS injured mice
ney U test p 0.0001 vs saline controls. N.S., not significant.ed aga
ox ind
. PS tr
almost
after d
and 4In contrast, we detected decreased expression of in-
PROTAMINE SULFATE BLADDER INJURY PROTECTS FROM DISTENTION BLADDER PAIN350Figure 5. Global gene expression profiles after UPEC or PS injury reflected nociception trends. PS injury resulted in global decrease
in proinflammatory gene expression by 24 hpi, which was maintained through 48 hpi (A). UPEC infection led to rapid global increase
in gene expression associated with inflammatory state by 6 hpi (B). PS treatment induced increases in various GO terms that peaked
at 6 (C), 12 (D) or 24 (E) hours. Genes that peaked at 6 hours were associated with cell cycling and those that peaked at 12 hours were
associated with transiently amplifying cell populations. qPCR analysis confirmed inflammatory profiles of UPEC and PS injuries (F to I).
Proinflammatory, pro-nociceptive cytokines IL-1 (F) and IL-6 (G) were up-regulated by UPEC and down-regulated by PS injury relative
to untreated bladder. Dotted line at  twofold indicates significant fold changes (G). Socs3 was also up-regulated by UPEC and
down-regulated by PS injury (H). Infection decreased mRNA expression of anti-inflammatory cytokine IL-4 (I) and PS injury up-
regulated it by 24 hpi.
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confirmed the suppressed immune response after PS
injury by qPCR, focusing on multiple proinflamma-
tory and pro-nociceptive cytokines. Expression of
IL-1, a proinflammatory, pro-nociceptive cytokine
that regulates the expression of other inflammatory
cytokines and is produced by the bladder in response
to inflammatory injury,19,22 was decreased in PS in-
jury but increased after UPEC infection. Expression of
the proinflammatory cytokine IL-6 was similarly af-
fected.14,21,27 Conversely, we observed decreased ex-
pression of IL-4, a prototypical anti-inflammatory cyto-
kine, in UPEC infected mice but increased expression
following PS injury.
PS injury showed an increase in the renewal
mechanisms initiating from transient amplifying
regulation rather than urothelial stem cell activa-
tion.7 It is possible that injuries, such as UPEC
infection, that activate stem cell mediated renewal
might amplify a feed forward loop that leads to
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